RKDA Stock Price | Arcadia Biosciences Inc P/E, Revenue, EPS, & Forecasts

Arcadia Biosciences Inc • RKDA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Arcadia Biosciences Inc

Ticker

RKDA

Trading on

NASDAQ

ISIN

US0390142042

Industry

Packaged Foods

Sector

Consumer Defensive

CEO

Thomas J. Schaefer C.F.A.

Headquarters

5950 Sherry Lane, Dallas, TX, United States, 75225

Employees

Website

arcadiabio.com

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Metrics

BasicAdvanced

Market cap

$4.7M

P/E ratio

EPS

-$6.77

Dividend Yield

0.00%

Beta

0.86

Forward P/E ratio

36.63

EBIDTA

$-13.7M

Ex dividend date

Price & volume

Market cap

$4.7M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

36.63

PEG ratio

-0.08

Trailing P/E

Price to sales

0.86

Price to book

0.46

Earnings

EPS

-$6.77

EPS estimate (current quarter)

-$0.81

EPS estimate (next quarter)

-$0.68

EBITDA

$-13.7M

Revenues (TTM)

$5.5M

Revenues per share (TTM)

$4.02

Technicals

Beta

0.86

52-week High

$6.44

52-week Low

$1.85

50-day moving average

$4.43

200-day moving average

$3.71

Short ratio

2.12

Short %

0.91%

Management effectiveness

ROE (TTM)

67.08%

ROA (TTM)

44.71%

Profit margin

106.29%

Gross profit margin

$1.1M

Operating margin

114.51%

Growth

Quarterly earnings growth (YoY)

28.50%

Quarterly revenue growth (YoY)

18.40%

Share stats

Outstanding Shares

1.4M

Float

1.4M

Insiders %

0.82%

Institutions %

10.74%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

$12.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$2.52

-$2.58

2.33%

Q4 • 23Beat

-$1.78

-$2.21

19.46%

Q1 • 24Beat

$0.78

$1.55

49.68%

Q2 • 24Beat

-$0.87

-$0.81

7.41%

Q3 • 24Beat

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$1.3M

$1.1M

81.24%

Q2 • 24

$1.5M

$-1.6M

104.88%

Q3 • 24

17.69%

251.93%

229.10%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$17.4M

$5.8M

33.41%

Q2 • 24

$15.2M

$5.1M

33.41%

Q3 • 24

12.25%

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-2.5M

$4.6M

$0M

$-2.5M

Q2 • 24

$-1.8M

$0.2M

$0M

$0.2M

Q3 • 24

28.66%

96.12%

∞%

110.09%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Arcadia Biosciences Inc share?

Arcadia Biosciences Inc shares are currently traded for undefined per share.

How many shares does Arcadia Biosciences Inc have?

Arcadia Biosciences Inc currently has 1.4M shares.

Does Arcadia Biosciences Inc pay dividends?

No, Arcadia Biosciences Inc doesn't pay dividends.

What is Arcadia Biosciences Inc 52 week high?

Arcadia Biosciences Inc 52 week high is $6.44.

What is Arcadia Biosciences Inc 52 week low?

Arcadia Biosciences Inc 52 week low is $1.85.

What is the 200-day moving average of Arcadia Biosciences Inc?

Arcadia Biosciences Inc 200-day moving average is $3.71.

Who is Arcadia Biosciences Inc CEO?

The CEO of Arcadia Biosciences Inc is Thomas J. Schaefer C.F.A..

How many employees Arcadia Biosciences Inc has?

Arcadia Biosciences Inc has 21 employees.

What is the market cap of Arcadia Biosciences Inc?

The market cap of Arcadia Biosciences Inc is $4.7M.

What is the P/E of Arcadia Biosciences Inc?

The current P/E of Arcadia Biosciences Inc is null.

What is the EPS of Arcadia Biosciences Inc?

The EPS of Arcadia Biosciences Inc is -$6.77.

What is the PEG Ratio of Arcadia Biosciences Inc?

The PEG Ratio of Arcadia Biosciences Inc is -0.08.

What do analysts say about Arcadia Biosciences Inc?

According to the analysts Arcadia Biosciences Inc is considered a buy.